Skip to main content Accesibility Help
×
×
Home

Advancing the pharmacological treatment of bipolar depression

  • Sophia Frangou
Abstract

Bipolar disorder is a recurring, often chronic, illness characterised by periods of mania and depression with variable inter-episode recovery. For the majority of patients it is the depressive component of this illness that contributes to most of the associated morbidity, social disability and mortality. Research and clinical experience suggest that acute treatment and prevention of depressive episodes is by far the most challenging aspect of the care of patients with the disorder. This review examines the contribution of depression to the course and outcome of bipolar disorder as well as diagnostic difficulties that often complicate treatment and may lead to inappropriate medication. Key studies that form the evidence base of treatment recommendation for bipolar depression are presented and areas of therapeutic uncertainty are highlighted.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Advancing the pharmacological treatment of bipolar depression
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Advancing the pharmacological treatment of bipolar depression
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Advancing the pharmacological treatment of bipolar depression
      Available formats
      ×
Copyright
References
Hide All
Akiskal, H. S. & Benazzi, F. (2004) Validating Kraepelin's two types of depressive mixed states: ‘depression with flight of ideas’ and ‘excited depression’. World Journal of Biological Psychiatry, 5, 107113.
Akiskal, H. S., Coryell, W., Leon, A. C. et al (1994) The time course of nonchronic major depressive disorder. Uniformity across episodes and samples. National Institute of Mental Health Collaborative Program on the Psychobiology of Depression - Clinical Studies. Archives of General Psychiatry, 51, 405410.
Altamura, A. C., Salvadori, D., Madaro, D. et al (2003) Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. Journal of Affective Disorders, 76, 267271.
Altshuler, L., Suppes, T., Black, D. et al (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal of Psychiatry, 160, 12521262.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (4th edn). Washington, DC: APA.
American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159 (suppl. 4), 150.
Angst, J., Gamma, A., Benazzi, F et al (2003) Diagnostic issues in bipolar disorder. European Neuropsychopharmacology, 13 (suppl. 2), S4350.
Baldessarini, R. J., Tondo, L. & Hennen, J. (2003) Lithium treatment and suicide risk in major affective disorders: update and new findings. Journal of Clinical Psychiatry, 64 (suppl. 5), 4452.
Ballenger, J. C. & Post, R. M. (1980) Carbamazepine in manic-depressive illness: a new treatment. American Journal of Psychiatry, 137, 782790.
Baron, M., Gershon, E. S., Rudy, V. et al (1975) Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Archives of General Psychiatry, 32, 11071111.
Bauer, M. S. & Mitchner, L. (2004) What is a ‘mood stabilizer’? An evidence-based response. American Journal of Psychiatry, 161, 318.
Baumhackl, U., Bizière, K., Fischbach, R. et al (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM–III): an Austrian double-blind, multicentre study. British Journal of Psychiatry, 155 (suppl. 6), 785835.
Bowden, C. L., Calabrese, J. R., McElroy, S.L. et al (2000) A randomized, placebo-controlled 12-month trial of valproate and lithium in treatment of outpatients with bipolar I disorder. Valproate Maintenance Study Group. Archives of General Psychiatry, 57, 481489.
Bowden, C. L., Calabrese, J. R., Sachs, G et al (2003) Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry, 60, 392400.
Calabrese, J. R., Markovitz, P. J., Kimmel, S. E. et al (1992) Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. Journal of Clinical Psychopharmacology, 12 (suppl. 1), 535565.
Calabrese, J. R., Bowden, C. L., McElroy, S. L. et al (1999a) Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. American Journal of Psychiatry, 156, 10191023.
Calabrese, J. R., Bowden, C. L., Sachs, G. S. et al (1999b) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Journal of Clinical Psychiatry, 60, 7988.
Calabrese, J. R., Bowden, C. L., Sachs, G. S. et al (2003) Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry, 64, 10131024.
Ciapparelli, A., Dell'Osso, L., Bandettini di Poggio, A. et al (2003) Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. Journal of Clinical Psychiatry, 64, 451458.
Cohn, J. B., Collins, G., Ashbrook, E. et al (1989) A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. International Clinical Psychopharmacology, 4, 313322.
Collaborative Working Group on Clinical Trial Evaluations (1998) Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Journal of Clinical Psychiatry, 59 (suppl. 12), 4145.
Dickerson, F. B., Boronow, J. J., Stallings, C. R. et al (2004) Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatric Services (Washington, D.C.), 55, 5458.
Fieve, R. R., Platman, S. R. & Plutchik, R. R. (1968) The use of lithium in affective disorders. I: Acute endogenous depression. American Journal of Psychiatry, 125, 487491.
Geddes, J. R., Burgess, S., Hawton, K. et al (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 16, 217222.
Ghaemi, S. N. & Goodwin, F. K. (2001) Long-term naturalistic treatment of depressive symptoms in bipolar illness with valproate vs. lithium in the setting of minimal antidepressant use. Journal of Affective Disorders, 65, 281287.
Ghaemi, S. N., Sachs, G. S., Chiou, A. M. et al (1999) Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? Journal of Affective Disorders, 52, 135144.
Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y. et al (2004) Antidepressant treatment in bipolar versus unipolar depression. American Journal of Psychiatry, 161, 163165.
Goodwin, G. M. (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 17, 149173.
Goodwin, F. K., Fireman, B., Simon, G. E. et al (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290, 14671473.
Greil, W., Ludwig-Mayerhofer, W., Erazo, N. et al (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study. Journal of Affective Disorders, 43, 151161.
Gyulai, L., Bowden, C. L., McElroy, S. L. et al (2003) Maintenance efficacy of valproate in the prevention of bipolar depression. Neuropsychopharmacology, 28, 13741382.
Hantouche, E. G., Akiskal, H. S., Lancrenon, S. et al (1998) Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). Journal of Affective Disorders, 50, 163173.
Harrow, M., Goldberg, J. F., Grossman, L. S. et al (1990) Outcome in manic disorders. A naturalistic follow-up study. Archives of General Psychiatry, 47, 665671.
Himmelhoch, J. M., Thase, M. E., Mallinger, A. G. et al (1991) Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry, 148, 910916.
Isometsa, E. T., Henriksson, M. M., Aro, H. M. et al (1994) Suicide in bipolar disorder in Finland. American Journal of Psychiatry, 151, 10204102.
Judd, L. L., Akiskal, H. S., Schettler, P. J. et al (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530537.
Judd, L. L., Akiskal, H. S., Schettler, P. J. et al (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry, 60, 261269.
Keller, M. B. (1988) The course of manic–depressive illness. Journal of Clinical Psychiatry, 49 (suppl.), 47.
Kessler, R. C., McGonagle, K. A., Zhao, S. et al (1994) Lifetime and 12-month prevalence of DSM–III–R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 819.
Kessler, R. C., Rubinow, D. R., Holmes, C. et al (1997) The epidemiology of DSM–III–R bipolar I disorder in general population survey. Psychological Medicine, 27, 10791089.
Lambert, P. A. & Venaud, G. (1992) Comparative study of valpromide versus lithium in treatment of affective disorders. Nervure: Journal de Psychiatrie, 5, 5765.
Leverich, G. S., Altshuler, L. L., Frye, M. A. et al (2003) Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. Journal of Clinical Psychiatry, 64, 506–15.
Lish, J. D., Dime-Meenan, S., Whybrow, P. C. et al (1994) The National Depressive and Manic–Depressive Association (DMDA) survey of bipolar members. Journal of Affective Disorders, 31, 281294.
MacQueen, G. M., Glenda, M., Young, L. et al (2001) A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatrica Scandinavica, 103, 163170.
Mitchell, P. B., Wilhelm, K., Parker, G. et al (2001) The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. Journal of Clinical Psychiatry, 62, 212216.
Nemeroff, C. B., Evans, D. L., Gyulai, L. et al (2001) Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry, 58, 906912.
Noyes, R., Dempsey, G. M., Blum, A. et al (1974) Lithium treatment in depression. Comprehensive Psychiatry, 15, 187193.
Okuma, T., Inanaga, K., Otsuki, S. et al (1981) A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic–depressive illness. Psychopharmacology, 73, 9596.
Patsalos, P. N. & Perucca, E. (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology, 2, 473481.
Peet, M. (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. British Journal of Psychiatry, 164, 549550.
Post, R. M., Uhde, T. W., Ballenger, J. C. et al (1983) Carbamazepine and its –10,11–epoxide metabolite in plasma and CSF: relationship to antidepressant response. Archives of General Psychiatry, 1983, 40, 673676.
Post, R. M., Uhde, T. W., Roy-Byrne, P. P. et al (1986) Antidepressant effects of carbamazepine. The American Journal of Psychiatry, 143, 2934.
Post, R. M., Altshuler, L. L., Frye, M. A. et al (2001a) Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders, 3, 259265.
Post, R. M., Nolen, W. A., Kupka, R. W. et al (2001b) The Stanley Foundation Bipolar Network. I. Rationale and methods. British Journal of Psychiatry, 178 (suppl. 41), s169s176.
Post, R. M., Leverich, G. S., Nolen, W. A. et al (2003) A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disorders, 5, 396406.
Prien, R. F., Caffey, E. M. Jr. & Klett, C. J. (1973) Prophylactic efficacy of lithium carbonate in manic–depressive illness: report of the Veteran's Administration and National Institute of Mental Health collaborative study group. Archives of General Psychiatry, 28, 337341.
Prien, R. F., Klett, C. J. & Caffey, E. M. (1974) Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry, 131, 198203.
Quraishi, S. & Frangou, S. (2002) Neuropsychology of bipolar disorder: a review. Journal of Affective Disorder, 72, 209226.
Raymont, V., Bettany, D. & Frangou, S. (2003) The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. European Psychiatry, 18, 1317.
Regier, D. A., Farmer, M. E. & Rae, D. S. (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264, 25112518.
Sachs, G. S., Lafer, B., Stoll, A. L. et al (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. Journal of Clinical Psychiatry, 55, 391393.
Simpson, S. G. & DePaulo, J. R. (1991) Fluoxetine treatment of bipolar II depression. Journal of Clinical Psychopharmacology, 11, 5254.
Sokolski, K. N. & Denson, T. F. (2003) Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27, 863866.
Stokes, P. E., Shamoian, C. A., Stoll, P. M. et al (1971) Efficacy of lithium as acute treatment of manic–depressive illness. Lancet, 1, 319325.
Thase, M. E., Mallinger, A. G., McKnight, D. et al (1992) Treatment of imipramine-resistant recurrent depression. IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. American Journal of Psychiatry, 149, 195198.
Thies-Flechtner, K., Muller-Oerlinghausen, B., Seibert, W. et al (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry, 29, 103107.
Tohen, M., Vieta, E., Calabrese, J. et al (2003) Efficacy of olanzapine and olanzapine–fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry, 60, 10791088.
Vieta, E., Goikolea, J. M., Corbella, B. et al, (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Journal of Clinical Psychiatry, 62, 818825.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Worrall, E. P., Moody, J. P., Peet, M. et al (1979) Controlled studies of the acute antidepressant effects of lithium. British Journal of Psychiatry, 135, 255262.
Yatham, L. N., Srisurapanont, M., Zis, A. P. et al (1997) Comparative studies of the biological distinction between unipolar and bipolar depressions. Life Science, 61, 14451455.
Young, L. T., Joffe, R. T., Robb, J. C. et al (2000) Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. American Journal of Psychiatry, 157, 124126.
Zarate, C. A. Jr., Tohen, M. & Baldessarini, R. J. (1995) Clozapine in severe mood disorders. Journal of Clinical Psychiatry, 56, 411417.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Advancing the pharmacological treatment of bipolar depression

  • Sophia Frangou
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *